Aptys Pharma Overview
- Year Founded
-
2002
- Status
-
Out of Business
- Employees
-
19
- Latest Deal Type
-
Out of Business
Aptys Pharma General Information
Description
Operator of a pharmaceutical laboratory intended to specialize in formulation design. The company specializes in formulating or reformulating molecules and provides analytical growth and quality control of medicines, enabling pharmaceutical companies to receive the support and qualification of a production plant.
Contact Information
Website
www.aptyspharma.comCorporate Office
- Biopôle Clermont-Limagne
- 5 Rue Emile Duclaux
- 63360 Saint Beauzire
- France
Corporate Office
- Biopôle Clermont-Limagne
- 5 Rue Emile Duclaux
- 63360 Saint Beauzire
- France
Aptys Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Out of Business | 06-Aug-2025 | Completed | Out of Business | |||
| 6. Grant | 01-Sep-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 15-Jan-2020 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 3. Later Stage VC | 29-Jun-2018 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2017 | $631K | $636K | Completed | Generating Revenue | |
| 1. Seed Round | 01-Dec-2008 | $636K | $636K | Completed | Generating Revenue |
Aptys Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ABSA 2019 | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 3,060 | $1.113761 | $54.57 | $54.57 | 1x | $54.57 | 1.53% | |
| Ordinary | 19,220 | $1.113761 | $14.48 | $14.48 | 1x | $14.48 | 9.62% |
Aptys Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aptys Pharma Patents
Aptys Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4279069-A1 | A pharmaceutical composition for use in preventing and/or reducing hepatotoxicity induced by acetaminophen | Inactive | 20-May-2022 | ||
| WO-2023223223-A1 | A pharmaceutical composition for use in preventing and/or reducing hepatotoxicity induced by acetaminophen | Inactive | 20-May-2022 | ||
| ES-2953126-T3 | A method for manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained in this way | Active | 14-Jan-2019 | ||
| AU-2020209883-A1 | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | Inactive | 14-Jan-2019 | ||
| EP-3679926-A1 | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | Inactive | 14-Jan-2019 | A61K31/5545 |
Aptys Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aptys Pharma FAQs
-
When was Aptys Pharma founded?
Aptys Pharma was founded in 2002.
-
Where is Aptys Pharma headquartered?
Aptys Pharma is headquartered in Saint Beauzire, France.
-
What is the size of Aptys Pharma?
Aptys Pharma has 19 total employees.
-
What industry is Aptys Pharma in?
Aptys Pharma’s primary industry is Pharmaceuticals.
-
Is Aptys Pharma a private or public company?
Aptys Pharma is a Private company.
-
What is Aptys Pharma’s current revenue?
The current revenue for Aptys Pharma is .
-
How much funding has Aptys Pharma raised over time?
Aptys Pharma has raised $3.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
